U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06949059) titled 'Intravenous Hydromorphone for the Treatment of Acute Pain' on April 14.
Brief Summary: To observe the efficacy and safety of hydromorphone in the treatment of acute chest pain, and to explore the potential advantages of hydromorphone for analgesia in patients with acute chest pain, so as to provide more theoretical basis for individualized analgesia and rapid recovery in patients with acute chest pain.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Acute Chest Pain
Intervention:
DRUG: Hydromorphone
Hydromorphone 1mg was given intravenously and conventional treatment was performed at the same time.
Recruitme...